Global Protein Binding Assays Market, By Technology (Equilibrium Dialysis, Affinity Electrophoresis, Ultrafiltration, Ultracentrifugation, Surface Plasmon Resonance, Others), Product and Services (Instrument, Kits and Reagents, Services), End-Users (Pharmaceutical and Biotechnology Companies, CROs, Consulting Firms, Others) – Industry Trends and Forecast to 2030.
Protein Binding Assays Market Analysis and Size
Rise in the availability of numerous advanced technologies utilized for protein binding is the vital factor escalating the market growth, also rise in the volume of expenditure carried out for advancing the technologies available for development of pharmaceuticals and rise in the incidences of drug failures during the latter stages giving rise to usage of better components and understanding of pharmaceutical development are the major factors among others driving the global protein binding assays market. Moreover, rising CRO industry and increase in the research and development activities in the market will further create new opportunities for global protein binding assays market in the forecasted period of 2023 to 2030.
Data Bridge Market Research analyses that the global protein binding assays market which was USD 438.00 million in 2022, and is expected to reach USD 903.50 million by 2030, and is expected to undergo a CAGR of 9.7% during the forecast period 2023-2030. This indicates that the market value. “Pharmaceutical and Biotechnology Companies,” dominates the end user segment of the global protein binding assays market owing to increasing pharmaceutical and biopharmaceutical companies investing in the preclinical screening activities which are helping them in the late-stage failures and for the development of therapeutics segment. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Protein Binding Assays Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Technology (Equilibrium Dialysis, Affinity Electrophoresis, Ultrafiltration, Ultracentrifugation, Surface Plasmon Resonance, Others), Product and Services (Instrument, Kits and Reagents, Services), End-Users (Pharmaceutical and Biotechnology Companies, CROs, Consulting Firms, Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), General Electric (U.S.), Sovicell (Germany), Cyprotex (U.K.), Bioduro.(U.S.), ADMEcell, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Sartorius Stedim BioOutsource Limited (Germany), and Bio-Rad Laboratories, Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Protein binding assays are the type of compounds that are used for the manufacturing of numerous pharmaceuticals as they are able to identify and provide researchers and scientists with invaluable information for the reactions between molecules. They also provide insights into the concentration of proteins present during a specific reaction between molecules. This information is important due to the detection of effects that protein will have on the consumer of pharmaceuticals being developed consisting of these proteins.
Global Protein Binding Assays Market Dynamics
Drivers
- Increase in the Demand for Protein Binding Usage
Protein fixation estimation is critical for protein cleaning, electrophoresis, cell science, atomic science, and research applications. Protein binding assays aid in improving therapeutic effects and reducing the amount of target molecule. There has been a growing demand for protein binding assays in recent years due to the increasing importance of proteins in biological processes and the development of new technologies for studying protein-ligand interactions. The advancements in drug discovery, growing understanding of protein-protein interactions, growing demand for personalized medicine, and technological advancements in high-throughput screening are the key factors supporting the global protein binding assays market demand.
- Growing Demand for Advanced Therapies, Boosting Drug Discovery and Development
Protein binding assay is considered essential in preclinical processes involved in drug development. Several biotechnological and pharmaceutical companies are undertaking initiatives to address the growing demand for advanced therapies, thereby boosting drug discovery and development.
According to U.S. FDA, 59 novel therapeutics and biologics were approved by Center for Drug Evaluation and Research (CDER) in 2018 as compared to 46 new drugs approved in 2017. Therefore, increase in the number of drug candidates being screened and approved annually drives the adoption of protein binding assays.
Opportunity
- Growing Awareness and Expansion of Biotechnology and Pharmaceutical Sectors
Growing awareness levels is presumed to be contributing toward market growth. The aforementioned factor is believed to boost the adoption for a wide range of indications, which is expected to boost global protein binding assays market over the forecast period 2023-2030. Pharmaceutical companies are investing in preclinical screening activities for preventing late-stage failures in development of therapeutics.
Moreover, the demand for protein binding assays is not only limited to developed countries but is also being witnessed in the developing countries which will further act as driver that will lead to the growth of the global protein binding assays market in the above mentioned projected timeframe.
Restraint/Challenge
- Dearth of Information and Skills Associated with Utilization of Protein Binding Assays
On the other hand, rise in the issues with existing technologies which will likely to act as market restraints factor for the growth of the protein binding assays in the above mentioned projected timeframe. Moreover, dearth of information and skills associated with utilization of protein binding assays all over the globe and rise in the complicated nature of standards present for the designing and development of assays will projected to become the biggest and foremost challenge for the growth of the market in the forecast period of 2023-2030.
Recent Developments
- In February 2019, Charles River signed an agreement to acquire Citoxlab to strengthen its market position in the field of drug discovery and development
- In June 2018, a majority of pharmaceutical firms invested approximately USD 1.13-5.65 million in preclinical testing. Pharmaceutical companies are investing in preclinical screening activities for preventing late-stage failures in development of therapeutics
Global Protein Binding Assays Market Scope
The global protein binding assays market is segmented on the basis of technology, products and services, and end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
- Equilibrium Dialysis
- Affinity Electrophoresis
- Ultrafiltration
- Ultracentrifugation
- Surface Plasmon Resonance
- Others
Product and Services
- Instrument
- Kits and Reagents
- Services
End-Users
- Pharmaceutical and Biotechnology Companies
- CROs
- Consulting Firms
- Others
Global Protein Binding Assays Market Regional Analysis/Insights
The global protein binding assays market is analysed and market size insights and trends are provided by country, technology, products and services, and end-users as mentioned above.
The countries covered in the global protein binding assays market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to dominate the global protein binding assays market due to rise in the presence of key players and increased funding from public and private entities have augmented drug discovery and development and rise in the volume of expenditure carried out for advancing the technologies available for development of pharmaceuticals in this region.
Asia-Pacific is expected to grow at the highest growth rate during the forecast period of 2023 to 2030 due to rise in the availability of numerous advanced technologies utilized for protein binding in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global protein binding assays market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global protein binding assays market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global protein binding assays market. The data is available for historic period 2015-2020.
Competitive Landscape and Global Protein Binding Assays Market Share Analysis
The protein binding assays market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global protein binding assays market.
Some of the major players operating in the global protein binding assays market are:
- Merck KGaA (Germany)
- Thermo Fisher Scientific Inc. (U.S.)
- General Electric (U.S.)
- Sovicell (Germany)
- Cyprotex (U.K.)
- Bioduro (U.S.)
- ADMEcell, Inc. (U.S.)
- Beckman Coulter, Inc. (U.S.)
- Sartorius Stedim BioOutsource Limited (Germany)
- Bio-Rad Laboratories, Inc. (U.S.)
SKU-